image
Healthcare - Biotechnology - NASDAQ - US
$ 3.99
-9.32 %
$ 109 M
Market Cap
-99.75
P/E
BALANCE SHEET
26.9 M ASSETS
-0.28%
38.5 M LIABILITIES
30.43%
-11.6 M EQUITY
-352.39%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Fennec Pharmaceuticals Inc.
image
Current Assets 26.9 M
Cash & Short-Term Investments 13.3 M
Receivables 8.81 M
Other Current Assets 4.78 M
Non-Current Assets 6 K
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 6 K
Current Liabilities 7.55 M
Accounts Payable 3.78 M
Short-Term Debt 21 K
Other Current Liabilities 3.75 M
Non-Current Liabilities 30.9 M
Long-Term Debt 30.9 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Jun-2004 Jun-2003 Jun-2002 Jun-2001 Jun-2000
ASSETS
Cash & Cash Equivalents 13.3 23.8 21.1 30.3 13.7 22.8 28.3 3.9 0.9 2.3 1.7 2.3 5.3 5.9 0.7 5.3 16.2 5.7 12.0 13.7 2.2 0.2 9.4 0.1
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.2 7.1 0 5.4 0 0
Receivables 8.8 1.5 0 0 0 0 0 0 0 0 0 0 0 0 69 K 0.1 0.2 0.1 0.1 0.3 22.3 K 0.1 0.1 29.9 K
Inventory 2.2 0.6 0 0 0 0 0 0 0 0 0 0 0 0 75 K 0.1 0.2 94 K 59 K 0.2 0.3 0.3 0.000001 0
Other Current Assets 2.6 0.8 1.3 1.1 0.2 0.2 0.1 46 K 77 K 65 K 89 K 62 K 54 K 46 K 79 K 99 K 0.2 0.1 0.1 0.5 0.6 0.3 0.5 0.3
Total Current Assets 26.9 26.7 22.4 31.4 13.9 22.9 28.4 4.0 1.0 2.4 1.8 2.4 5.4 6.0 0.8 5.6 16.6 5.9 13.4 21.7 3.3 6.2 9.9 0.4
PP&E 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0.6 0.3 0.9 0.4 0.5 0.6 0.5 0.2
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0 14.2 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 6 K 0.2 27 K 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 19.6 21.8 0 0 0
Other Assets 0 0 0 1.1 0 0.2 0.1 46 K 77 K 65 K 89 K 62 K 54 K 46 K 0 0 0 0 0 0 0 0 0 1
Total Assets 26.9 26.9 22.4 31.4 14.1 22.9 28.4 4.0 1.0 2.4 1.8 2.4 5.4 6.0 0.8 6.1 17.2 16.6 28.4 41.7 25.7 6.8 10.5 0.6
LIABILITIES
Accounts Payable 3.8 2.4 0.8 1.6 1.6 1.0 0.9 0.2 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.5 0.5 2.1 1.4 1.5 1.5 1.0 0.6 0.4
Short Term Debt 21 K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 24.6 K 24.6 K
Other Current Liabilities 3.8 2.2 0.9 0.8 0.7 0.6 0.8 0.2 0.2 1.5 3.0 7.1 5.1 10.6 0.1 1.9 1.9 (1.0) (3.9) (8.9) 483 47.5 K (0.1) 59.3 K
Total Current Liabilities 7.6 4.6 1.7 2.3 2.3 1.6 1.6 0.4 0.5 1.8 3.2 7.3 5.5 10.9 0.4 2.4 2.4 4.7 2.7 1.5 1.1 0.7 0.5 0.5
Long Term Debt 30.9 24.9 5.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 33.4 K
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.6 5.2 7.2 7.9 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 K 0.6 0.7 0.7 0.6 92.1 K 1.3 42 K 0.1 76.8 K
Total Liabilities 38.5 29.5 6.6 2.3 2.3 1.6 1.6 0.4 0.5 1.8 3.2 7.3 5.5 10.9 0.4 3.0 3.1 9.0 8.4 8.7 10.3 0.7 0.6 0.6
EQUITY
Common Stock 144.3 142.6 140.8 140.7 106.4 106.4 103.0 74.5 69.2 68.7 66.8 66.0 66.0 64.9 64.9 64.9 64.9 46.5 41.3 48.3 0 0 0 0
Retained Earnings (219.2) (203.2) (179.5) (162.1) (144.0) (131.3) (121.4) (114.3) (111.5) (110.9) (108.7) (110.5) (105.4) (108.8) (101.0) (98.0) (84.4) (71.5) (52.4) (25.5) (16.6) (9.1) (5.4) (3.0)
Other Accumulative Comprehensive Income/Loss 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 5.8 5.8 22.2 12.9 0 0 0
Total Equity (11.6) (2.6) 15.8 29.1 11.9 21.3 26.8 3.6 0.5 0.6 (1.5) (5.0) (0.1) (4.9) 0.4 3.1 14.1 7.6 20.1 33.0 15.3 6.1 9.8 46.7 K
Total Liabilities and Equity 26.9 26.9 22.4 31.4 14.1 22.9 28.4 4.0 1.0 2.4 1.8 2.4 5.4 6.0 0.8 6.1 17.2 16.6 28.4 41.7 25.7 6.8 10.5 0.6
SHARES OUTSTANDING
Common Shares Outstanding 26.6 26.3 26.0 23.7 19.9 18.9 15.0 12.7 10.8 9.9 9.7 8.2 8.0 7.1 3.1 3.1 2.8 1.1 0.9 0.6 0.3 0.2 0.1 0.5